Stay updated with breaking news from David Borah. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WALTHAM, Mass and DUBLIN, May 03, 2024 -- Mural Oncology plc , a clinical-stage immuno-oncology company leveraging its core competencies in immune cell modulation and protein engineering to develop...
WALTHAM, Mass. and DUBLIN, Ireland, April 24, 2024 -- Mural Oncology plc , a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to...
24.04.2024 - WALTHAM, Mass. and DUBLIN, Ireland, April 24, 2024 (GLOBE NEWSWIRE) - Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet ...
WALTHAM, Mass. and DUBLIN, Ireland, April 04, 2024 -- Mural Oncology plc , a clinical-stage immuno-oncology company leveraging its core competencies in immune cell modulation and protein...
Lead product candidate, nemvaleukin, is being developed to treat a wide range of solid tumors and is currently in two potentially registrational c...